Free shipping on all orders over $ 500

Evolocumab

Cat. No. M1595

All AbMole products are for research use only, cannot be used for human consumption.

Evolocumab Structure
Synonym:

AMG 145 ; Repatha

Size Price Availability Quantity
1mg USD 480  USD480 In stock
2mg USD 680  USD680 In stock
5mg USD 1080  USD1080 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Evolocumab is a fully human monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9). Evolocumab binds to PCSK9 and inhibit PCSK9 from binding to LDL receptors on the liver surface. PCSK9 is a protein that targets LDL receptors for degradation and thereby reduces the liver's ability to remove LDL-C, or "bad" cholesterol, from the blood. In the absence of PCSK9, there are more LDL receptors on the surface of liver cells to remove LDL-C from the blood. Evolocumab has antioxidant and cytoprotective activities against H2O2-induced oxidative damage to endothelial cells. Evolocumab may also negatively regulate activation of the TLR-4/NF-κB signaling pathway to prevent inflammation.

Chemical Information
Molecular Weight 141788.63
Formula C6242H9648N1668O1996S56
CAS Number 1256937-27-5
Storage -80°C for long term
References

[1] Marian McDonagh, et al. J Manag Care Spec Pharm. A Systematic Review of PCSK9 Inhibitors Alirocumab and Evolocumab

[2] Weinreich M, et al. Cardiol Rev. Antihyperlipidemic therapies targeting PCSK9.

Related PCSK9 Products
Alirocumab

Alirocumab is a humanized IgG1 PCSK9 monoclonal antibody that can be used in the study of hypercholesterolemia.

Schizandrol-B

Schisantherin B (Gomisin-B; Wuweizi ester-B; Schisantherin-B) is a lignan from Schisandra chinensis that promotes liver enlargement in mice through activation of the PXR and YAP pathways and inhibits PCSK9 protein expression with an IC50 value of 1.10 μM.

R-IMPP

R-impp (PF-00932239) is an anti-secreting inhibitor of PCSK9 (IC50=4.8 μM), which can inhibit PCSK9 protein translation by targeting the ribosomes at the time of 80S.

SBC-115076

Sbc-115076 is an effective inhibitor of the preprotein invertase Bacillus subtilis proteinase/Kexin 9 (PCSK9). PCSK9 is a preprotein invertase that plays an important role in LDL receptor metabolism.

SBC-110736

SBC-110736 is a novel inhibitor of proprotein convertase subtilisin kexin type 9 (PCSK9).

  Catalog
Abmole Inhibitor Catalog




Keywords: Evolocumab, AMG 145 ; Repatha supplier, PCSK9, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.